F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market


The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.


BY CHRISTINA JEWETT | NYTimes Health | Disclosure

Comments